Sulfonamide hypersensitivity syndrome

Sulfonamide hypersensitivity syndrome is similar to anticonvulsant hypersensitivity syndrome, but the onset is often sooner in the treatment course, generally after 7–14 days of therapy.[1]: 118–9 

It is considered immune-mediated.[2]

See also

References

  1. ↑ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
  2. ↑ Cribb AE, Pohl LR, Spielberg SP, Leeder JS (August 1997). "Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins". J. Pharmacol. Exp. Ther. 282 (2): 1064–71. PMID 9262376.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.